Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) FCF Margin (2016 - 2025)

Dexcom (DXCM) has disclosed FCF Margin for 16 consecutive years, with 15.25% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin fell 63.0% to 15.25% in Q4 2025 year-over-year; TTM through Dec 2025 was 23.11%, a 747.0% increase, with the full-year FY2025 number at 23.11%, up 747.0% from a year prior.
  • FCF Margin was 15.25% for Q4 2025 at Dexcom, down from 47.91% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 47.91% in Q3 2025 to a low of 14.24% in Q1 2021.
  • A 5-year average of 12.64% and a median of 13.37% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: crashed -2788bps in 2021, then soared 3903bps in 2025.
  • Dexcom's FCF Margin stood at 3.67% in 2021, then surged by 131bps to 8.46% in 2022, then fell by -7bps to 7.84% in 2023, then surged by 103bps to 15.88% in 2024, then fell by -4bps to 15.25% in 2025.
  • Per Business Quant, the three most recent readings for DXCM's FCF Margin are 15.25% (Q4 2025), 47.91% (Q3 2025), and 18.05% (Q2 2025).